Dr. Willerth, a Full Professor in Biomedical Engineering, holds a Canada Research Chair in Biomedical Engineering at the University of Victoria where she has dual appointments in the Department of Mechanical Engineering and the Division of Medical Sciences. She also holds an appointment with the School of Biomedical Engineering at the University of British Columbia. She runs an active research group that investigates different methods of engineering neural tissues from stem cells. She is an active member of the steering committee of the B.C. Regenerative Medicine Initiative and the Stem Cell Network. She also serves as a staff scientist at Creative Destruction Lab. She also was the President of the Canadian Biomaterials Society– serving a three-year term as President-Elect then President and Past President from 2017-2019. She recently founded the start-up company - Axolotl Biosciences.
Research Keywords & Expertise
Biomaterials
Stem Cells
Tissue Engineering
3D printing
neurosciece
Bioprinting and Biomat...
Fingerprints
44%
Stem Cells
26%
Tissue Engineering
18%
Biomaterials
13%
3D printing
5%
Bioprinting and Biomaterials
Short Biography
Dr. Willerth, a Full Professor in Biomedical Engineering, holds a Canada Research Chair in Biomedical Engineering at the University of Victoria where she has dual appointments in the Department of Mechanical Engineering and the Division of Medical Sciences. She also holds an appointment with the School of Biomedical Engineering at the University of British Columbia. She runs an active research group that investigates different methods of engineering neural tissues from stem cells. She is an active member of the steering committee of the B.C. Regenerative Medicine Initiative and the Stem Cell Network. She also serves as a staff scientist at Creative Destruction Lab. She also was the President of the Canadian Biomaterials Society– serving a three-year term as President-Elect then President and Past President from 2017-2019. She recently founded the start-up company - Axolotl Biosciences.